SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001628280-21-002134
Filing Date
2021-02-12
Accepted
2021-02-12 17:16:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G schedule13g_formatherapeut.htm SC 13G 81031
  Complete submission text file 0001628280-21-002134.txt   82825
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Subject) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91541 | Film No.: 21629666
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G